91 related articles for article (PubMed ID: 385383)
1. [Experimental aspergillosis in mice].
Haller I
Dermatologica; 1979; 159(Suppl 1):187-90. PubMed ID: 385383
[TBL] [Abstract][Full Text] [Related]
2. Experimental murine aspergillosis. Comparison of amphotericin B and a new polyene antifungal drug, SCH 28191.
Graybill JR; Kaster SR
Am Rev Respir Dis; 1984 Feb; 129(2):292-5. PubMed ID: 6364905
[TBL] [Abstract][Full Text] [Related]
3. Poor efficacy of amphotericin B-based therapy in CNS aspergillosis.
Schwartz S; Ruhnke M; Ribaud P; Reed E; Troke P; Thiel E
Mycoses; 2007 May; 50(3):196-200. PubMed ID: 17472616
[TBL] [Abstract][Full Text] [Related]
4. Activity of micafungin (FK463) against an itraconazole-resistant strain of Aspergillus fumigatus and a strain of Aspergillus terreus demonstrating in vivo resistance to amphotericin B.
Warn PA; Morrissey G; Morrissey J; Denning DW
J Antimicrob Chemother; 2003 Apr; 51(4):913-9. PubMed ID: 12654746
[TBL] [Abstract][Full Text] [Related]
5. Tuftsin-mediated immunoprophylaxis against an isolate of Aspergillus fumigatus shows less in vivo susceptibility to amphotericin B.
Khan MA; Ahmad N; Moin S; Mannan A; Wajahul H; Pasha ST; Khan A; Owais M
FEMS Immunol Med Microbiol; 2005 Jun; 44(3):269-76. PubMed ID: 15907448
[TBL] [Abstract][Full Text] [Related]
6. [Chemotherapy of aspergillus lung disease].
Scholer HJ
Mykosen; 1983 Apr; 26(4):173-96. PubMed ID: 6306462
[No Abstract] [Full Text] [Related]
7. [An experimental study of the therapeutic effect of interleukin-2 and interleukin-12 with and without amphotericin B on pulmonary fungal infection].
Zhang CR; Tang YC; Kawakami K; Zhang TT; Zhang KX; Zhu JX
Zhonghua Jie He He Hu Xi Za Zhi; 2004 Apr; 27(4):234-6. PubMed ID: 15144612
[TBL] [Abstract][Full Text] [Related]
8. In vivo resistance of a laboratory-selected Aspergillus fumigatus isolate to amphotericin B.
Manavathu EK; Cutright JL; Chandrasekar PH
Antimicrob Agents Chemother; 2005 Jan; 49(1):428-30. PubMed ID: 15616327
[TBL] [Abstract][Full Text] [Related]
9. A comparison of the efficacy of itraconazole, amphotericin B and 5-fluorocytosine in the treatment of Aspergillus fumigatus endocarditis in the rabbit.
Longman LP; Martin MV
J Antimicrob Chemother; 1987 Nov; 20(5):719-24. PubMed ID: 2828301
[TBL] [Abstract][Full Text] [Related]
10. Prophylactic administration of liposomal amphotericin B is superior to treatment in a murine model of invasive aspergillosis after hematopoietic cell transplantation.
BitMansour A; Brown JM
J Infect Dis; 2002 Jul; 186(1):134-7. PubMed ID: 12089676
[TBL] [Abstract][Full Text] [Related]
11. Successful treatment of aspergillus brain abscess in a child with acute lymphoblastic leukemia.
Ng A; Gadong N; Kelsey A; Denning DW; Leggate J; Eden OB
Pediatr Hematol Oncol; 2000 Sep; 17(6):497-504. PubMed ID: 10989471
[TBL] [Abstract][Full Text] [Related]
12. Comparative study on the efficacy of AmBisome and Fungizone in a mouse model of pulmonary aspergillosis.
Takemoto K; Yamamoto Y; Ueda Y; Sumita Y; Yoshida K; Niki Y
J Antimicrob Chemother; 2006 Apr; 57(4):724-31. PubMed ID: 16446374
[TBL] [Abstract][Full Text] [Related]
13. Combination therapy with micafungin and amphotericin B for invasive pulmonary aspergillosis in an immunocompromised mouse model.
Nagasaki Y; Eriguchi Y; Uchida Y; Miyake N; Maehara Y; Kadowaki M; Harada M; Akashi K; Shimono N
J Antimicrob Chemother; 2009 Aug; 64(2):379-82. PubMed ID: 19465436
[TBL] [Abstract][Full Text] [Related]
14. [Invasive aspergillosis on a surgical intensive care unit].
Kujath P; Klempien I; Muhl E; Kämmerer R
Mycoses; 2000; 43 Suppl 2():23-7. PubMed ID: 11291572
[TBL] [Abstract][Full Text] [Related]
15. Efficacy and pharmacodynamics of flucytosine monotherapy in a nonneutropenic murine model of invasive aspergillosis.
te Dorsthorst DT; Verweij PE; Meis JF; Mouton JW
Antimicrob Agents Chemother; 2005 Oct; 49(10):4220-6. PubMed ID: 16189101
[TBL] [Abstract][Full Text] [Related]
16. [Antifungal agents in otorhinolaryngology].
Dupont B; Drouhet E
Ann Otolaryngol Chir Cervicofac; 1982; 99(12):575-80. PubMed ID: 7158918
[TBL] [Abstract][Full Text] [Related]
17. Treatment failure in invasive aspergillosis: susceptibility of deep tissue isolates following treatment with amphotericin B.
Paterson PJ; Seaton S; Prentice HG; Kibbler CC
J Antimicrob Chemother; 2003 Nov; 52(5):873-6. PubMed ID: 14519673
[TBL] [Abstract][Full Text] [Related]
18. [Curative treatment of invasive aspergillosis].
Dupont B
Pathol Biol (Paris); 1994 Sep; 42(7):688-93. PubMed ID: 7877863
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of high loading doses of liposomal amphotericin B in the treatment of experimental invasive pulmonary aspergillosis.
Gavaldà J; Martín T; López P; Gomis X; Ramírez JL; Rodríguez D; Len O; Puigfel Y; Ruiz I; Pahissa A
Clin Microbiol Infect; 2005 Dec; 11(12):999-1004. PubMed ID: 16307554
[TBL] [Abstract][Full Text] [Related]
20. Therapy of murine aspergillosis with amphotericin B in combination with rifampin of 5-fluorocytosine.
Arroyo J; Medoff G; Kobayashi GS
Antimicrob Agents Chemother; 1977 Jan; 11(1):21-5. PubMed ID: 319750
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
